Clinical feasibility and oncological safety of targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: A prospective registry study

被引：1
|
作者：
Wu, S. [1 ]
Li, J. [1 ]
Wang, Y. [2 ]
Liu, G. [1 ]
机构：
[1] Fudan Univ Shanghai Canc Ctr, Breast Surg Dept, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页码：S624 / S625
页数：2
相关论文
共 50 条
  • [1] Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study
    Wu, Si-Yu
    Li, Jian-Wei
    Wang, Yu-Jie
    Jin, Kai-Rui
    Yang, Ben-Long
    Li, Jun-Jie
    Yu, Xiao-Li
    Mo, Miao
    Hu, Na
    Shao, Zhi-Ming
    Liu, Guang-Yu
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (07) : 1863 - 1870
  • [2] Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
    Boileau, Jean-Francois
    Poirier, Brigitte
    Basik, Mark
    Holloway, Claire M. B.
    Gaboury, Louis
    Sideris, Lucas
    Meterissian, Sarkis
    Arnaout, Angel
    Brackstone, Muriel
    McCready, David R.
    Karp, Stephen E.
    Trop, Isabelle
    Lisbona, Andre
    Wright, Frances C.
    Younan, Rami J.
    Provencher, Louise
    Patocskai, Erica
    Omeroglu, Atilla
    Robidoux, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 258 - U150
  • [3] Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry
    -Jones, Catherine Loveland
    Gaughan, John
    Caudle, Abigail
    Murphy, Brittany
    Samiian, Laila
    Byrum, Stephanie
    Brill, Kristen
    Germaine, Pauline
    Zhang, Xinmin
    Yoon-Flannery, Kay
    Carter, Teralyn
    Lopez, Adrian
    Gruner, Ryan
    Fantazzio, Michele
    Kuerer, Henry
    EJSO, 2024, 50 (04):
  • [4] Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer
    Kuemmel, Sherko
    Heil, Joerg
    Bruzas, Simona
    Breit, Elisabeth
    Schindowski, Dorothea
    Harrach, Hakima
    Chiari, Ouafaa
    Hellerhoff, Karin
    Bensmann, Elena
    Hanf, Volker
    Grasshoff, Sven-Thomas
    Deuschle, Petra
    Belke, Kerstin
    Polata, Silke
    Paepke, Stefan
    Warm, Mathias
    Meiler, Johannes
    Schindlbeck, Christian
    Ruhwedel, Wencke
    Beckmann, Ulrike
    Groh, Ulrich
    Dall, Peter
    Blohmer, Jens-Uwe
    Traut, Alexander
    Reinisch, Mattea
    JAMA SURGERY, 2023, 158 (08) : 807 - 815
  • [5] A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients
    Kuemmel, Sherko
    Heil, Joerg
    Rueland, Anna
    Seiberling, Christine
    Harrach, Hakima
    Schindowski, Dorothea
    Lubitz, Juliane
    Hellerhoff, Karin
    Ankel, Christine
    Grasshoff, Sven-Thomas
    Deuschle, Petra
    Hanf, Volker
    Belke, Kerstin
    Dall, Peter
    Dorn, Julia
    Kaltenecker, Gabriele
    Kuehn, Thorsten
    Beckmann, Ulrike
    Potenberg, Jochem
    Blohmer, Jens-Uwe
    Kostara, Athina
    Breit, Elisabeth
    Holtschmidt, Johannes
    Traut, Eugen
    Reinisch, Mattea
    ANNALS OF SURGERY, 2022, 276 (05) : E553 - E562
  • [6] Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study
    Cabioglu, Neslihan
    Karanlik, Hasan
    Gulcelik, Mehmet Ali
    Kocer, Havva Belma
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Tukenmez, Mustafa
    Uras, Cihan
    Ozkurt, Enver
    Akgul, Gokhan Giray
    Emiroglu, Selman
    Bademler, Suleyman
    Dag, Ahmet
    Trabulus, Didem Can
    Yildirim, Nilufer
    Cakmak, Guldeniz Karadeniz
    Sen Oran, Ebru
    Kara, Halil
    Basaran, Gul
    Altinok, Ayse
    Ugurlu, M. Umit
    Senol, Kazim
    Zengel, Baha
    Karaman, Niyazi
    Varol, Ecenur
    Dilege, Ece
    Bolukbasi, Yasemin
    Akcan, Alper
    Ersoy, Yeliz Emine
    Soyder, Aykut
    Ozbas, Serdar
    Velidedeoglu, Mehmet
    Ozcinar, Beyza
    Utkan, N. Zafer
    Citgez, Bulent
    Celik, Burak
    Zer, Leyla
    Sakman, Gurhan
    Yeniay, Levent
    Dogan, Lutfi
    Dogan, Mutlu
    Erozgen, Fazilet
    Goktepe, Berk
    Agcaoglu, Orhan
    Kivilcim, Taner
    Balci, Fatih Levent
    Gulluoglu, Bahadir M.
    Polat, Ayfer Kamali
    Ibis, Kamuran
    Ozmen, Vahit
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Biopsy-proven lymph nodes predict axillary nodal response following neoadjuvant chemotherapy in node-positive breast cancer
    Crown, Angelena
    Grumley, Janie
    BREAST JOURNAL, 2019, 25 (05): : 1023 - 1024
  • [8] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Morency, Dominique
    Dumitra, Sinziana
    Parvez, Elena
    Martel, Karyne
    Basik, Mark
    Robidoux, Andre
    Poirier, Brigitte
    Holloway, Claire M. B.
    Gaboury, Louis
    Sideris, Lucas
    Meterissian, Sarkis
    Boileau, Jean-Francois
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4337 - 4345
  • [9] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Dominique Morency
    Sinziana Dumitra
    Elena Parvez
    Karyne Martel
    Mark Basik
    André Robidoux
    Brigitte Poirier
    Claire M. B. Holloway
    Louis Gaboury
    Lucas Sideris
    Sarkis Meterissian
    Jean-François Boileau
    Annals of Surgical Oncology, 2019, 26 : 4337 - 4345
  • [10] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Morency, D.
    Dumitra, S.
    Parvez, E.
    Basik, M.
    Boileau, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S8 - S8
12345